EHS
EHS

Embolic debris captured in most patients undergoing TAVR

A cerebral embolic protection system captured embolic debris in nearly all patients undergoing transcatheter aortic valve replacement, regardless of valve type, according to recent data published in JACC: Cardiovascular Interventions.
The researchers conducted a pooled analysis of 246 patients from the prospective SENTINEL and SENTINEL-H trials. Of these patients, 16% received an Evolut R valve (Medtronic), 15% received a Lotus valve (Boston Scientific), 59% received a Sapien 3 valve (Edwards Lifesciences) and 10% received a Sapien XT valve (Edwards Lifesciences).
Results showed that embolic
EHS
Back to top button